novo nordisk a/s-b (NOVOB:Copenhagen)
Esper Boel Ph.D.
Former Head of Biotechnology, Novo Nordisk A/S
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
Dr. Esper Boel, Ph.D. has been the Chief Technology Officer of Symphogen A/S since February 2015 and serves as its Head of Preclinical Research and Development. Prior to joining Symphogen, Dr. Boel served as Corporate Vice President of Novo Nordisk A/S in Denmark and Head of the Biotechnology Unit, which is its core facility in the disciplines of molecular biology, recombinant expression of therapeutic proteins in bacterial and mammalian cell systems, cell biology, bioprocess ...
Novo AlléPhone: 45 44 44 88 88
Bagsvaerd, Capital Region of Denmark 2880
Fax: 45 44 49 05 55
Board Members Memberships*
Bachelor's Degree 1979
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|